Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.68

-2.4%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tom pope who wrote (14093)	11/14/2004 2:23:58 PM
From: Arthur Radley	of 52153

Fully realizing that I'm the only person on this board that qualifies(by age) to get the AARP Bulletin I must say the current issue has some very revealing data as it relates to the drug industry and public opinion: 1) Two in three Americans now believe that drug prices are "unreasonably high." 2) 60% favor federal price controls as a solution. 3) Only 44% think drug companies serve consumers well, down from 79% seven years ago, the sharpest drop in esteem of ANY industry. (Thank goodness we have the tobacco industry to bring up the lowest rank, but isn't it ironic that we have the tobacco industry that kills and we now have the drug industry that is suppose to save lives and where they both rank now in public viewpoints.) Could the now public remarks being made by Dr. Rost, vice president of marketing for PFE, be the first break of insiders in the industry and could this lead to a barrage of such "confessions"?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next